Instrumentl eFile Render
Object ID: 202213169349300541 - Rendered 2024-04-27
TIN: 53-0241211
Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
Attach to Form 990.
Go to
www.irs.gov/Form990
for instructions and the latest information.
OMB No. 1545-0047
20
21
Open to Public Inspection
Name of the organization
PHARMACEUTICAL RESEARCH & MANUFACTURERS
OF AMERICA
Employer identification number
53-0241211
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
First-class or charter travel
Housing allowance or residence for personal use
Travel for companions
Payments for business use of personal residence
Tax idemnification and gross-up payments
Health or social club dues or initiation fees
Discretionary spending account
Personal services (e.g., maid, chauffeur, chef)
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain
.....
1b
Yes
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a?
....
2
Yes
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
Compensation committee
Written employment contract
Independent compensation consultant
Compensation survey or study
Form 990 of other organizations
Approval by the board or compensation committee
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment?
.............
4a
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan?
.........
4b
Yes
c
Participate in, or receive payment from, an equity-based compensation arrangement?
.........
4c
Yes
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization?
....................
5a
b
Any related organization?
.......................
5b
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization?
..................
6a
b
Any related organization?
......................
6b
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III
............
7
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III
..........................
8
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)?
.........................
9
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2021
Schedule J (Form 990) 2021
Page
2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees.
Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note.
The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A)
Name and Title
(B)
Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC
(C)
Retirement and other deferred compensation
(D)
Nontaxable
benefits
(E)
Total of columns
(B)(i)-(D)
(F)
Compensation in column (B) reported as deferred on prior Form 990
(i)
Base
compensation
(ii)
Bonus & incentive
compensation
(iii)
Other
reportable compensation
1
Stephen J Ubl
PRESIDENT & CEO
(i)
(ii)
1,793,955
-------------
0
2,232,204
-------------
0
648,212
-------------
0
1,475,154
-------------
0
32,965
-------------
0
6,182,490
-------------
0
1,626,040
-------------
0
2
Lori Reilly
EVP, ADVOCACY/COO
(i)
(ii)
866,030
-------------
0
1,121,569
-------------
0
4,988
-------------
0
483,801
-------------
0
42,425
-------------
0
2,518,813
-------------
0
438,513
-------------
0
3
James C Stansel
GEN COUNSEL & EVP LAW, SECY
(i)
(ii)
708,441
-------------
0
703,139
-------------
0
6,410
-------------
0
386,961
-------------
0
32,867
-------------
0
1,837,818
-------------
0
303,676
-------------
0
4
Jennifer Bryant
EVP, POLICY/RESEARCH
(i)
(ii)
590,719
-------------
0
555,637
-------------
0
14,654
-------------
0
305,103
-------------
0
34,423
-------------
0
1,500,536
-------------
0
161,776
-------------
0
5
Richard Moscicki MD
CMO & EVP, SCIENCE/RG ADVOCACY
(i)
(ii)
575,013
-------------
0
517,824
-------------
0
6,160
-------------
0
319,528
-------------
0
34,869
-------------
0
1,453,394
-------------
0
251,272
-------------
0
6
Paul A Aines
CFO & EVP OF ADMINISTRATION
(i)
(ii)
505,675
-------------
0
400,345
-------------
0
5,401
-------------
0
284,114
-------------
0
28,314
-------------
0
1,223,849
-------------
0
166,284
-------------
0
7
Robin E Palchus
SVP, HUMAN RESOURCES
(i)
(ii)
406,770
-------------
0
308,836
-------------
0
5,580
-------------
0
193,800
-------------
0
30,455
-------------
0
945,441
-------------
0
119,835
-------------
0
8
Debra DeShong
EVP, PUBLIC AFFAIRS
(i)
(ii)
489,190
-------------
0
0
-------------
0
4,560
-------------
0
279,000
-------------
0
29,725
-------------
0
802,475
-------------
0
0
-------------
0
9
Shannon C Monsif
SVP, ALLIANCE
(i)
(ii)
484,801
-------------
0
481,851
-------------
0
25,438
-------------
0
217,889
-------------
0
41,047
-------------
0
1,251,026
-------------
0
172,012
-------------
0
10
Brian Toohey
SVP, INT'L ADVOCACY
(i)
(ii)
496,562
-------------
0
624,123
-------------
0
5,169
-------------
0
-4,862
-------------
0
14,831
-------------
0
1,135,823
-------------
0
214,051
-------------
0
11
Scott LaGanga
SVP, STATE GOVT ADVOCACY
(i)
(ii)
512,581
-------------
0
512,066
-------------
0
4,700
-------------
0
200,356
-------------
0
36,835
-------------
0
1,266,538
-------------
0
221,155
-------------
0
12
Anne Esposito
SVP, FEDERAL ADVOCACY
(i)
(ii)
528,458
-------------
0
448,338
-------------
0
6,790
-------------
0
241,180
-------------
0
15,200
-------------
0
1,239,966
-------------
0
0
-------------
0
13
Amy Jackson
ExecDIR, INT'L ADVOCACY
(i)
(ii)
189,201
-------------
0
78,898
-------------
0
680,352
-------------
0
29,000
-------------
0
27,378
-------------
0
1,004,829
-------------
0
0
-------------
0
14
Lisa M Joldersma
SVP, POLICY/RESEARCH
(i)
(ii)
455,543
-------------
0
444,589
-------------
0
4,050
-------------
0
31,900
-------------
0
37,714
-------------
0
973,796
-------------
0
153,513
-------------
0
Schedule J (Form 990) 2021
Schedule J (Form 990) 2021
Page
3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference
Explanation
SCHEDULE J, PART I, LINE 1A:
FIRST CLASS TRAVEL: THE PRESIDENT IS AUTHORIZED TO TRAVEL USING FIRST CLASS. TRAVEL FOR COMPANIONS: COMPANIONS OCCASIONALLY TRAVEL WITH PHRMA EXECUTIVES ON BUSINESS TRAVEL. IN SUCH CASES, COMPANION TRAVEL IS INCLUDED IN THE TAXABLE INCOME OF THE PHRMA EXECUTIVE. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: AMY JACKSON (EXECUTIVE DIRECTOR, INTERNATIONAL ADVOCACY), THE JAPAN REPRESENTATIVE, AN EXPATRIATE RESIDING IN TOKYO, JAPAN AND ONE OF PHRMA'S TOP 5 COMPENSATED EMPLOYEES, IS TAX-EQUALIZED. GROSS-UP PAYMENTS MAY BE PROCESSED FOR PHRMA EXECUTIVES WHEN A FRINGE BENEFIT IS CONSIDERED TAXABLE INCOME AND THERE IS A BUSINESS REQUIREMENT GIVING RISE TO THE TAXABLE FRINGE BENEFIT. HEALTH AND WELLNESS BENEFIT: ALL PHRMA EMPLOYEES ARE ELIGIBLE TO PARTICIPATE IN PHRMA'S HEALTH AND WELLNESS BENEFIT UP TO $1,250 ANNUALLY. THE VALUE OF THIS BENEFIT IS CONSIDERED TAXABLE INCOME.
SCHEDULE J, PART I, LINES 4B-C:
PHRMA SPONSORS A NON-QUALIFIED SECTION 457(F) DEFERRED COMPENSATION PLAN. AMOUNTS PAID OUT UNDER THIS PLAN ARE INCLUDED IN PART VII (WHEN PAID) AND SCHEDULE J, RESPECTIVELY (WHEN PAID, EARNED AND REPORTED IN A PRIOR YEAR). NAME: 457F (PRIOR YEAR LTIP & DEF. COMP PAID IN 2020); 457F (LTIP & DEF. COMP AWARDED IN 2021 BUT NOT PAID UNTIL FUTURE YEARS) PRIOR YEAR PAID CURRENT YEAR AWARDED STEPHEN UBL: $1,626,040 $1,446,154 LORI REILLY: $ 438,513 $ 530,256 JAMES STANSEL: $ 303,676 $ 357,961 JENNIFER BRYANT: $ 161,776 $ 298,494 RICHARD MOSCICKI: $ 251,272 $ 290,528 SCOTT LAGANGA: $ 221,155 $ 208,550 PAUL AINES: $ 166,284 $ 255,114 ROBIN PALCHUS: $ 119,835 $ 164,800 SHANNON MONSIF: $ 172,012 $ 199,438 ANNE ESPOSITO: $ 0 $ 212,180 DEBRA DESHONG: $ 0 $ 250,000 BRIAN TOOHEY: $ 214,051 $ 0 LISA JOLDERSMA: $ 153,513 $ 0
Schedule J (Form 990) 2021
Additional Data
Software ID:
Software Version: